T0 | T1 | T2 | T3 | T4 | T5 | ||
---|---|---|---|---|---|---|---|
HR (bpm) | Group C (n = 40) | 77.4 ± 11.3 | 74.4 ± 9.8 | 74.3 ± 10.3 | 72.7 ± 9.7 | 73.0 ± 9.0 | 75.9 ± 9.7 |
Group P (n = 40) | 78.1 ± 10.5 | 75.0 ± 12.0 | 77.3 ± 13.3 | 70.4 ± 12.5a | 71.3 ± 12.4 | 71.9 ± 10.6 | |
P-value | 0.767 | 0.823 | 0.262 | 0.356 | 0.478 | 0.082 | |
NiMAP (mmHg) | Group C (n = 40) | 108.8 ± 10.1 | 95.7 ± 10.5a | 92.8 ± 10.2a | 90.3 ± 11.1a | 94.1 ± 11.6a | 96.2 ± 10.8a |
Group P (n = 40) | 112.7 ± 12.3 | 97.2 ± 10.3a | 93.7 ± 10.1a | 91.2 ± 12.2a | 93.2 ± 12.3a | 95.4 ± 10.5a | |
P-value | 0.125 | 0.520 | 0.698 | 0.732 | 0.737 | 0.738 | |
RR (bpm) | Group C (n = 40) | 17.4 ± 3.8 | 15.7 ± 3.6c | 15.5 ± 4.1c | 15.5 ± 3.5c | 16.8 ± 2.9 | 17.9 ± 2.6 |
Group P (n = 40) | 16.3 ± 3.9 | 14.2 ± 4.2 | 13.6 ± 4.4ac | 13.7 ± 3.6ac | 15.5 ± 2.9 | 16.7 ± 3.0 | |
P-value | 0.195 | 0.108 | 0.045* | 0.023* | 0.049* | 0.057 | |
SpO2 (%) | Group C (n = 40) | 100.0 [99.0–100.0] | 100.0 [99.0–100.0] | 99.0 [98.0–100.0] | 99.0 [98.3–100.0]a | 99.0 [98.0–100.0] | 99.0 [98.0–100.0] |
Group P (n = 40) | 100.0 [99.0–100.0] | 100.0 [99.0–100.0] | 99.0 [98.0–100.0] | 99.0 [97.0–100.0]ab | 99.0 [97.3–100.0] | 99.0 [98.0–100.0] | |
P-value | 0.651 | 0.891 | 0.807 | 0.131 | 0.223 | 0.336 |